Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novocure Ltd Ord Sh (NVCR)

Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why NovoCure Stock Dived by 13% This Week

Investors found the announced changes to the company's C-suite unsettling.

NVCR : 17.45 (-2.19%)
Chips, Glorious Chips!

Someone's gotta make 'em, and someone's gotta buy 'em.

AMD : 155.95 (-0.50%)
NVDA : 116.00 (-1.59%)
META : 561.35 (+0.40%)
MSFT : 435.27 (-0.78%)
GOOGL : 163.59 (+0.89%)
AMZN : 191.60 (+0.91%)
INTC : 21.84 (+3.31%)
ISRG : 486.20 (-0.78%)
DXCM : 70.43 (-2.07%)
GOOG : 164.64 (+0.86%)
PODD : 236.58 (-0.46%)
TNDM : 44.63 (+0.40%)
NovoCure (NVCR) Q2 2024 Earnings Call Transcript

NVCR earnings call for the period ending June 30, 2024.

NVCR : 17.45 (-2.19%)
NovoCure: Q2 Earnings Snapshot

NovoCure: Q2 Earnings Snapshot

NVCR : 17.45 (-2.19%)
NovoCure (NVCR) Q1 2024 Earnings Call Transcript

NVCR earnings call for the period ending March 31, 2024.

NVCR : 17.45 (-2.19%)
NovoCure: Q1 Earnings Snapshot

NovoCure: Q1 Earnings Snapshot

NVCR : 17.45 (-2.19%)
Why NovoCure Stock Soared 18.3% This Week

Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.

NVCR : 17.45 (-2.19%)
Why Novocure Stock Is Jumping Today

Novocure had good news mixed with some not-so-good news.

NVCR : 17.45 (-2.19%)
Stocks Settle Higher on Lower Bond Yields and Quarter-End Window Dressing

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. Stock indexes...

$SPX : 5,702.55 (-0.19%)
SPY : 568.25 (-0.17%)
$DOWI : 42,063.36 (+0.09%)
DIA : 420.57 (+0.10%)
$IUXX : 19,791.49 (-0.24%)
QQQ : 482.44 (-0.19%)
ZNZ24 : 114-270s (+0.10%)
CTAS : 204.16 (+0.21%)
MRK : 117.17 (-0.05%)
MRVL : 73.87 (-1.35%)
EXR : 180.41 (+0.18%)
MDT : 89.34 (-0.15%)
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024

Stocks that traded heavily or had substantial price changes on Wednesday: Merck, Cintas rise; GameStop, MiMedx fall

NVCR : 17.45 (-2.19%)
NCNO : 30.44 (-0.94%)
JNJ : 164.16 (-0.40%)
MRK : 117.17 (-0.05%)
GME : 21.85 (+11.99%)
CTAS : 204.16 (+0.21%)
MKKGY : 35.2300 (-5.60%)

Barchart Exclusives

Snag This Biotech Stock Before November, Here's Why
With Viking Therapeutics making a splash in the weight-loss drug arena, one analyst is encouraging investors to snap up the stock before a November catalyst. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar